Chromosomal Microarray Analysis genetic testing to be an IHCP covered service

Effective April 1, 2014, the Indiana Health Coverage Programs (IHCP) will add Chromosomal Microarray Analysis (CMA- 81228, 81229) genetic testing as a covered service. Coverage applies to dates of service (DOS) on or after January 1, 2014. This service will effectively replace IHCP coverage of Comparative Genomic Hybrization (CGH) microarray testing, which will be eliminated as a covered service effective March 31, 2014. These tests require a prior authorization (PA). CMA testing is considered a first-line test in postnatal evaluation of individuals with unexplained developmental delay/intellectual delay (DD/ID) or Autism Spectrum Disorder (ASD) and multiple cognitive abnormalities not specific to a well defined genetic syndrome.